Newsroom
October 3, 2022
A device known as a bionic pancreas, which uses next-generation technology to automatically deliver insulin, was more effective at maintaining blood glucose (sugar) levels within normal range than standard-of-care management among people with type 1 diabetes, a new multicenter clinical trial has found.
September 28, 2022
Contacts: Will Sansom, UT Health San Antonio, (210) 567-2579, sansom@uthscsa.edu Andrea Wazir, University Health, (210) 358-2347, Andrea.Wazir@uhs-sa.com SAN ANTONIO (Sept. 28, 2022) — A device known as a bionic pancreas, which uses next-generation technology to automatically deliver insulin, was more effective at maintaining blood glucose (sugar) levels within normal range than standard-of-care management among people […]
September 28, 2022
Findings reported in Nature have implications for future dementia care, as well. Contact: Will Sansom, (210) 567-2579, sansom@uthscsa.edu SAN ANTONIO (Sept. 28, 2022) — Researchers from The University of Texas Health Science Center at San Antonio (UT Health San Antonio) are part of an international team that discovered 61 additional genetic loci associated with stroke and […]
September 26, 2022
Contact: Will Sansom, (210) 567-2579, sansom@uthscsa.edu SAN ANTONIO (Sept. 26, 2022) — One-third of 986 patients achieved long-term self-care of their type 2 diabetes after building trusting relationships with community health workers (promotores in Spanish) over 12 weeks, according to a newly published study by faculty of The University of Texas Health Science Center at San […]
September 23, 2022
Scientific leaders, including the Alzheimer’s Association and representatives from more than 25 countries, are working together with technical guidance from the World Health Organization to track the long-term impact of SARS-CoV-2 on the brain.
September 23, 2022
Contact: Will Sansom, (210) 567-2579, sansom@uthscsa.edu SAN ANTONIO (Sept. 23, 2022) — Carlayne E. Jackson, MD, a specialist in the treatment and research of neuromuscular disorders such as amyotrophic lateral sclerosis (ALS, Lou Gehrig’s disease), has been appointed chair of the Department of Neurology in the Joe R. and Teresa Lozano Long School of Medicine at […]
